Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12609000584235
ACTRN12609000584235
Completed
Phase 4

Impact of vitamin D status on risk of cardiovascular disease in healthy adults.

Department of Health0 sites100 target enrollmentJuly 14, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Health
Enrollment
100
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 14, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Healthy adults

Exclusion Criteria

  • •Treatment with 25\-hydroxy vitamin D or 1,25\-dihydroxy vitamin D
  • •Beta\-blocker medication
  • •Diabetes mellitus
  • •Atrial fibrillation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Effect of Vitamin D Supplementation on Cardiovascular and Respiratory Disease Event Rates, and the incidence of fracturesCardiovascular DiseaseRespiratory DiseaseNon-vertebral fracturesCancerCardiovascular - Coronary heart diseaseRespiratory - Chronic obstructive pulmonary diseaseInjuries and Accidents - FracturesCancer - Any cancer
ACTRN12611000402943niversity of Auckland5,110
Not yet recruiting
Not Applicable
Effects of Vitamin D on the cardiovascular autonomic functions of subjects who are working in High Altitude Areas, in excess of 15000ft, for 3 to 4 months. This study will shed light on the Autonomic Nervous System, a specialized system of nerves that has profound effects on Heart.
CTRI/2022/07/044289DGAFMS
Active, not recruiting
Not Applicable
The effect of vitamin D supplementation on cardiovascular risk factors in subjects with low serum 25-hydroxyvitamin D levelssubjects with serum 25-hydroxyvitamin D < 35 nmol/L will be included and the effect of vitamin D supplementation versus placebo tested regarding cardiovascular risk factorsTherapeutic area: Body processes [G] - Physiological processes [G07]
EUCTR2013-003514-40-NOniversity Hospital of North Norway
Completed
Not Applicable
Vitamin D Repletion in Coronary Artery DiseaseVitamin D DeficiencyCoronary Artery DiseaseEndothelial DysfunctionInflammation
NCT01570309Seth I. Sokol, M.D.96
Active, not recruiting
Not Applicable
Vitamin D therapy to reduce cardiovascular risk in Type 2 diabetes – the next steps
EUCTR2007-003767-51-GBResearch and Innovation Services, University of Dundee